Brief: Kalvista Initiates Konfident-Kid Trial For On-Demand Treatment
June 27 (Reuters) - Kalvista Pharmaceuticals Inc
KALV.O :
* KALVISTA INITIATES KONFIDENT-KID TRIAL FOR ON-DEMAND
TREATMENT
OF HEREDITARY ANGIOEDEMA ATTACKS WITH SEBETRALSTAT IN CHILDREN
AGED 2 TO 11
Source text for Eikon: ID:nBwbNQvvta
Further company coverage: KALV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy